Cerus (CERS) Non Operating Income (2010 - 2026)
Cerus (CERS) reported Non Operating Income of -$1.2 million for Q1 2026, up 32.83% on a YoY basis from -$905663.3 in Q1 2025, and up 15.52% sequentially from -$1.4 million in Q4 2025.
Cerus (CERS) Non Operating Income (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Non Operating Income data on file, last reported at -$1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 32.83% year-over-year to -$1.2 million; the trailing twelve-month figure through Mar 2026 stood at -$6.0 million (up 10.04% YoY), and the FY2025 full-year result was -$6.6 million, down 1.09% from the prior year.
- Non Operating Income improved to -$1.2 million in Q1 2026, from -$1.4 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of -$1.0 million in Q4 2024 to a low of -$3.4 million in Q4 2022.
- A 5-year average of -$1.8 million and a median of -$1.6 million in 2024 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income slumped 158.77% in 2022 and soared 56.3% in 2024, its largest moves.
- Tracing CERS's Non Operating Income over 5 years: stood at -$3.4 million in 2022, then surged by 32.7% to -$2.3 million in 2023, then surged by 56.3% to -$1.0 million in 2024, then slumped by 42.12% to -$1.4 million in 2025, then advanced by 15.52% to -$1.2 million in 2026.
- Business Quant data shows CERS's Non Operating Income at -$1.2 million in Q1 2026, -$1.4 million in Q4 2025, and -$1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | -1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.20 Mn |
| Dec 31, 2025 | -1.42 Mn |
| Sep 30, 2025 | -1.17 Mn |
| Jun 30, 2025 | -2.22 Mn |
| Mar 31, 2025 | -1.79 Mn |
| Dec 31, 2024 | -1.00 Mn |
| Sep 30, 2024 | -1.90 Mn |
| Jun 30, 2024 | -2.00 Mn |
| Mar 31, 2024 | -1.64 Mn |
| Dec 31, 2023 | -2.29 Mn |
| Sep 30, 2023 | -1.97 Mn |
| Jun 30, 2023 | -1.59 Mn |
| Mar 31, 2023 | -1.42 Mn |
| Dec 31, 2022 | -3.41 Mn |
| Sep 30, 2022 | -1.01 Mn |
| Jun 30, 2022 | -1.48 Mn |
| Mar 31, 2022 | -2.36 Mn |
| Dec 31, 2021 | -2.09 Mn |
| Sep 30, 2021 | -1.24 Mn |
| Jun 30, 2021 | -883,000.00 |